Argenx Se (ARGX) Debt Ratio (2015 - 2018)

Argenx Se's (ARGX) quarterly Debt Ratio came in at 0.06 in Q2 2018, up 45.24% on a QoQ basis from 0.04 in Q4 2017.

Argenx Se (ARGX) Debt Ratio (2015 - 2018) Analysis & Trends

Argenx Se (ARGX) has 4 years of Debt Ratio data on file, last reported at 0.06 in Q2 2018.

Quarterly Debt Ratio changed N/A year-over-year to 0.06 in Q2 2018, while the trailing twelve-month figure through Jun 2018 was 0.06 (changed N/A YoY) and the FY2017 annual result came in at 0.04, down 64.19% from the prior year.
Debt Ratio climbed to 0.06 in Q2 2018, from 0.04 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 0.12 in Q4 2016 to a low of 0.04 in Q4 2017.
A 4-year average of 0.08 and a median of 0.08 in 2015 frame the typical range for Debt Ratio.
Annual changes were most pronounced in 2016 — Debt Ratio gained 16.62% — and 2017, when it plunged 64.19%.
Tracing ARGX's Debt Ratio over 4 years: stood at 0.1 in 2015, then gained by 16.62% to 0.12 in 2016, then sank by 64.19% to 0.04 in 2017, then soared by 45.24% to 0.06 in 2018.
The last three Debt Ratio figures came in at 0.06 (Q2 2018), 0.04 (Q4 2017), and 0.12 (Q4 2016), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	0.05
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	0.12
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.47
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	0.26
10	Roivant Sciences	26.16 Bn	26.85 Bn	1.16 Mn	-

Download Data